Skip to content
Disclosery

Artia Global Partners LP

Follow

13F filer, CIK 1937964, MIAMI, FL

Artia Global Partners LP reported $499,420,000 across 50 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 72.65% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001937964-26-000007

Period
2026-03-31
Reported value
$499M
Holdings
50
Top 10 weight
72.65%
New
11
Sold out
16

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AZNnew+95,376$18.8M
ALMSnew+325,046$7.16M
MRKnew+46,700$5.62M
TERNnew+104,800$5.53M
JNJnew+22,600$5.52M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ARGXreduced-34,960-$25.5M
UGLexited-442,119-$24.5M
QUREexited-1,023,539-$24.5M
AZNexited-190,752-$17.5M
VKTXreduced-538,634-$17.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001937964-26-000007, largest first. % of portfolio is the value over $443,523,456, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 52,939 shares; 2024Q4: 167,939 shares; 2025Q1: 318,239 shares; 2025Q2: 752,712 shares; 2025Q3: 732,212 shares; 2025Q4: 682,212 shares; 2026Q1: 628,712 shares 628,712$103M23.18%-53,500Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 225,453 shares; 2025Q4: 600,747 shares; 2026Q1: 600,747 shares 600,747$66.9M15.08%0Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 92,593 shares; 2024Q4: not reported; 2025Q1: 94,887 shares; 2025Q2: 30,700 shares; 2025Q3: 28,700 shares; 2025Q4: 50,500 shares; 2026Q1: 38,220 shares 38,220$35.2M7.93%-12,280Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,311,840 shares; 2025Q3: 1,999,702 shares; 2025Q4: 2,013,602 shares; 2026Q1: 2,013,602 shares 2,013,602$24M5.42%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,138 shares; 2024Q4: 11,311 shares; 2025Q1: 11,311 shares; 2025Q2: 78,311 shares; 2025Q3: 78,311 shares; 2025Q4: 64,699 shares; 2026Q1: 29,739 shares 29,739$21.7M4.9%-34,960Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,376 shares 95,376$18.8M4.24%newTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 54,285 shares; 2024Q4: 54,285 shares; 2025Q1: not reported; 2025Q2: 27,319 shares; 2025Q3: 194,838 shares; 2025Q4: 503,936 shares; 2026Q1: 503,936 shares 503,936$16.1M3.64%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 108,723 shares; 2025Q4: 205,090 shares; 2026Q1: 162,990 shares 162,990$13.7M3.08%-42,100Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 95,885 shares; 2024Q4: 284,190 shares; 2025Q1: 104,190 shares; 2025Q2: 104,190 shares; 2025Q3: 104,190 shares; 2025Q4: 104,190 shares; 2026Q1: 124,990 shares 124,990$12.2M2.74%+20,800Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 30,479 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,176 shares; 2025Q4: 144,376 shares; 2026Q1: 144,376 shares 144,376$10.8M2.44%0Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 156,300 shares; 2024Q4: 216,700 shares; 2025Q1: 316,700 shares; 2025Q2: 316,700 shares; 2025Q3: 628,367 shares; 2025Q4: 767,098 shares; 2026Q1: 767,098 shares 767,098$9.89M2.23%0Timeline
DGXQUEST DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 56,717 shares; 2025Q2: 81,717 shares; 2025Q3: 81,717 shares; 2025Q4: 40,817 shares; 2026Q1: 40,817 shares 40,817$8M1.8%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 325,046 shares 325,046$7.16M1.61%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 532,879 shares; 2024Q4: 90,279 shares; 2025Q1: 90,279 shares; 2025Q2: 96,479 shares; 2025Q3: 146,179 shares; 2025Q4: 719,365 shares; 2026Q1: 180,731 shares 180,731$5.88M1.33%-538,634Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 46,700 shares 46,700$5.62M1.27%newTimeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 104,800 shares 104,800$5.53M1.25%newTimeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 22,600 shares 22,600$5.52M1.25%newTimeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 119,741 shares; 2026Q1: 119,741 shares 119,741$4.8M1.08%0Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 172,185 shares; 2025Q2: 126,285 shares; 2025Q3: 96,285 shares; 2025Q4: 96,285 shares; 2026Q1: 96,285 shares 96,285$4.73M1.07%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 64,608 shares; 2025Q4: 138,508 shares; 2026Q1: 138,508 shares 138,508$4.33M0.98%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,440 shares; 2024Q4: 7,440 shares; 2025Q1: 7,440 shares; 2025Q2: 12,240 shares; 2025Q3: 12,240 shares; 2025Q4: 17,740 shares; 2026Q1: 17,740 shares 17,740$4.06M0.91%0Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,989 shares; 2026Q1: 24,989 shares 24,989$3.98M0.9%+7,000Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 40,000 shares; 2024Q4: 40,000 shares; 2025Q1: 40,000 shares; 2025Q2: 40,000 shares; 2025Q3: 40,000 shares; 2025Q4: 40,000 shares; 2026Q1: 65,000 shares 65,000$3.78M0.85%+25,000Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 41,100 shares; 2025Q3: 56,600 shares; 2025Q4: 137,800 shares; 2026Q1: 137,800 shares 137,800$3.73M0.84%0Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 129,800 shares; 2026Q1: 129,800 shares 129,800$3.6M0.81%0Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,992,367 shares; 2026Q1: 1,992,367 shares 1,992,367$3.49M0.79%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 18,437 shares 18,437$3.38M0.76%newTimeline
PROKPROKIDNEY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,838,411 shares; 2026Q1: 1,806,939 shares 1,806,939$3.23M0.73%-31,472Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,500 shares; 2025Q3: 14,500 shares; 2025Q4: 14,500 shares; 2026Q1: 14,500 shares 14,500$3.15M0.71%0Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: 5,000 shares; 2025Q3: 5,000 shares; 2025Q4: 5,000 shares; 2026Q1: 5,000 shares 5,000$2.96M0.67%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 33,407 shares; 2026Q1: 38,407 shares 38,407$2.8M0.63%+5,000Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 124,440 shares; 2024Q4: 293,851 shares; 2025Q1: 333,851 shares; 2025Q2: 22,951 shares; 2025Q3: 22,951 shares; 2025Q4: 22,951 shares; 2026Q1: 22,931 shares 22,931$2.42M0.54%-20Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 274,424 shares; 2024Q4: 494,424 shares; 2025Q1: 498,473 shares; 2025Q2: 494,424 shares; 2025Q3: 672,176 shares; 2025Q4: 533,698 shares; 2026Q1: 68,490 shares 68,490$2.29M0.52%-465,208Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,600 shares; 2025Q4: 41,600 shares; 2026Q1: 53,800 shares 53,800$2.29M0.52%+12,200Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 30,900 shares; 2025Q2: 30,900 shares; 2025Q3: 30,900 shares; 2025Q4: 70,700 shares; 2026Q1: 70,700 shares 70,700$2.1M0.47%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 65,500 shares 65,500$2.06M0.47%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,900 shares; 2026Q1: 15,576 shares 15,576$1.78M0.4%+2,676Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,400 shares; 2025Q4: 20,400 shares; 2026Q1: 20,400 shares 20,400$1.51M0.34%0Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 29,200 shares; 2025Q3: 29,200 shares; 2025Q4: 29,200 shares; 2026Q1: 29,200 shares 29,200$1.41M0.32%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 16,300 shares 16,300$1.07M0.24%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 102,900 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,900 shares 20,900$819K0.18%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,500 shares; 2026Q1: 2,500 shares 2,500$805K0.18%0Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 42,080 shares; 2026Q1: 42,080 shares 42,080$673K0.15%0Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,019 shares; 2026Q1: 17,019 shares 17,019$649K0.15%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,437 shares; 2024Q4: 204,045 shares; 2025Q1: 90,745 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,100 shares; 2026Q1: 4,900 shares 4,900$502K0.11%-3,200Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,886 shares 5,886$495K0.11%newTimeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,570 shares; 2026Q1: 28,970 shares 28,970$433K0.1%-12,600Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 205,324 shares; 2026Q1: 205,324 shares 205,324$363K0.08%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
INSMINSMED INC Stockput279,700$45.7M-140,300
MRNAMODERNA INC COMcall200,000$10.2Mnew

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
UGLPROSHARES TR II442,119$24.5Mshares
QUREUNIQURE NV1,023,539$24.5Mshares
AZNASTRAZENECA PLC-SPONS ADR190,752$17.5Mshares
CDTXCIDARA THERAPEUTICS INC70,824$15.6Mshares
ALNYALNYLAM PHARMACEUTICALS INC17,400$6.92Mshares
VTYXVENTYX BIOSCIENCES INC695,982$6.28Mshares
PVLAPALVELLA THERAPEUTICS INC NE59,200$6.2Mshares
UGLPROSHARES TR II100,000$5.55Mput
RNAMAVIDITY BIOSCIENCES INC60,100$4.34Mshares
SLNOSOLENO THERAPEUTICS INC50,000$2.31Mcall
UPBUPSTREAM BIO INC68,653$1.86Mshares
OCULOCULAR THERAPEUTIX INC141,061$1.71Mshares
ABVXABIVAX SA9,900$1.34Mcall
OCULOCULAR THERAPEUTIX INC85,200$1.03Mcall
ANROALTO NEUROSCIENCE INC29,192$520Kshares
LYRALYRA THERAPEUTICS INC COM NEW8,756$27Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001937964-26-000007 base2026-05-15acceptance time not in the bulk data set